We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+29.29%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$9.47B
AUM Growth
+$451M
Cap. Flow
+$1.13B
Cap. Flow %
11.96%
Top 10 Hldgs %
21.59%
Holding
903
New
107
Increased
255
Reduced
393
Closed
103

Top Buys

Rank Stock Value
1
BPMC
Blueprint Medicines
BPMC
+$51.9M
2
MRK icon
Merck
MRK
+$50.9M
3
DHR icon
Danaher
DHR
+$45.3M
4
TMO icon
Thermo Fisher Scientific
TMO
+$37.8M
5
JD icon
JD.com
JD
+$37.7M

Top Sells

Rank Stock Value
1
REGN icon
Regeneron Pharmaceuticals
REGN
+$103M
2
BABA icon
Alibaba
BABA
+$98.6M
3
CRM icon
Salesforce
CRM
+$62.5M
4
BMY icon
Bristol-Myers Squibb
BMY
+$59.4M
5
VRTX icon
Vertex Pharmaceuticals
VRTX
+$48.6M

Sector Composition

Rank Sector Weight
1 Healthcare 34.61%
2 Technology 20.94%
3 Consumer Discretionary 8.9%
4 Financials 8.59%
5 Communication Services 7.45%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ITW icon
351
Illinois Tool Works
ITW
$84.1B
$4.39M 0.05%
25,130
-8,485
-25% -$1.39M
LDOS icon
352
Leidos
LDOS
$14.4B
$4.32M 0.05%
46,127
+22,078
+92% +$2.17M
GBT
353
DELISTED
Global Blood Therapeutics, Inc.
GBT
$4.28M 0.05%
67,843
+22,843
+51% +$1.57M
ETSY icon
354
Etsy
ETSY
$8.12B
$4.26M 0.05%
+15,110
New +$1.12M
EPZM
355
DELISTED
Epizyme, Inc
EPZM
$4.26M 0.04%
265,014
+47,638
+22% +$832K
RDUS
356
DELISTED
Radius Health, Inc.
RDUS
$4.25M 0.04%
312,025
+50,000
+19% +$689K
MSI icon
357
Motorola Solutions
MSI
$72.1B
$4.23M 0.04%
30,155
-9,277
-24% -$1.31M
K
358
DELISTED
Kellanova
K
$4.22M 0.04%
68,024
-18,514
-21% -$1.12M
TSCO icon
359
Tractor Supply
TSCO
$16.3B
$4.22M 0.04%
160,060
-143,030
-47% -$3.13M
PLNT icon
360
Planet Fitness
PLNT
$4.45B
$4.21M 0.04%
69,524
+13,834
+25% +$831K
AMRN
361
Amarin Corp
AMRN
$297M
$4.19M 0.04%
30,300
-1,250
-4% -$172K
CVX icon
362
Chevron
CVX
$382B
$4.16M 0.04%
46,667
-54,940
-54% -$4.92M
SRE icon
363
Sempra
SRE
$58.1B
$4.14M 0.04%
70,560
-17,828
-20% -$1.1M
EXC icon
364
Exelon
EXC
$48.1B
$4.06M 0.04%
156,800
-47,582
-23% -$1.26M
YUMC icon
365
Yum China
YUMC
$15.7B
$4.05M 0.04%
84,220
-11,250
-12% -$531K
CSX icon
366
CSX Corp
CSX
$94B
$3.99M 0.04%
171,783
-32,166
-16% -$712K
NUAN
367
DELISTED
Nuance Communications, Inc.
NUAN
$3.97M 0.04%
+157,000
New +$3.28M
AKRO
368
DELISTED
Akero Therapeutics
AKRO
$3.94M 0.04%
158,000
+138,000
+690% +$3.15M
BLU
369
DELISTED
BELLUS Health Inc.
BLU
$3.93M 0.04%
+382,013
New +$3.87M
CME icon
370
CME Group
CME
$95.4B
$3.91M 0.04%
24,070
-6,994
-23% -$1.25M
RGA icon
371
Reinsurance Group of America
RGA
$15.5B
$3.91M 0.04%
49,883
+4,720
+10% +$436K
KURA icon
372
Kura Oncology
KURA
$793M
$3.91M 0.04%
+239,704
New +$3.46M
CNI icon
373
Canadian National Railway
CNI
$78.5B
$3.9M 0.04%
44,165
-20,611
-32% -$1.72M
COF icon
374
Capital One
COF
$128B
$3.88M 0.04%
61,977
-81,045
-57% -$5.05M
NSC icon
375
Norfolk Southern
NSC
$75.4B
$3.87M 0.04%
22,026
-2,533
-10% -$429K
13 14
15
16 17

Similar funds

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
A
AustralianSuper Melbourne, Australia $19.2B AUM 31.95% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $19.4B AUM 16.7% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return

Candriam SCA's Q2 2020 Portfolio in Review

As of Q2 2020, Candriam SCA held 903 positions worth $9.47B, up 5% from $9.02B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Candriam SCA deployed $1.13B of net new capital in Q2 2020, opening 107 new positions and adding to 255 existing holdings. Its largest new stake was JD.com: 744,410 shares worth $44.8M.

By sector, the portfolio is most concentrated in Healthcare at 35% of assets, up from 31% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Regeneron Pharmaceuticals, an estimated $103M trimmed.

  • Candriam SCA's largest Q2 2020 buy was JD.com: 744,410 shares worth $44.8M.
  • Candriam SCA added most to Blueprint Medicines in Q2 2020, an estimated $51.9M increase.
  • Candriam SCA's biggest Q2 2020 reduction was Regeneron Pharmaceuticals, cutting an estimated $103M.
  • Candriam SCA fully exited Salesforce in Q2 2020, selling an estimated $62.5M.
  • Candriam SCA's ten largest holdings make up 22% of its $9.47B portfolio in Q2 2020.
  • Candriam SCA opened 107 new positions and closed 103 in Q2 2020.
  • Candriam SCA's portfolio value rose 5% quarter-over-quarter to $9.47B.

Based on Candriam SCA's 13F filing for Q2 2020, filed 23 Jul 2020.